Literature DB >> 20511231

Mechanistic insights into the events that lead to synergistic induction of interleukin 6 transcription upon activation of the aryl hydrocarbon receptor and inflammatory signaling.

Brett C DiNatale1, Jennifer C Schroeder, Lauren J Francey, Ann Kusnadi, Gary H Perdew.   

Abstract

The aryl hydrocarbon receptor (AHR) is the ligand-activated transcription factor responsible for mediating the toxicological effects of dioxin and xenobiotic metabolism. However, recent evidence has implicated the AHR in additional, nonmetabolic physiological processes, including immune regulation. Certain tumor cells are largely nonresponsive to cytokine-mediated induction of the pro-survival cytokine interleukin (IL) 6. We have demonstrated that multiple nonresponsive tumor lines are able to undergo synergistic induction of IL6 following combinatorial treatment with IL1beta and the AHR agonist 2,3,7,8-tetrachlorodibenzo-p-dioxin. Such data implicate the AHR in tumor expansion, although the mechanistic basis for the AHR-dependent synergistic induction of IL6 has not been determined. Here, we demonstrate that ligand-activated AHR is involved in priming the IL6 promoter through binding to nonconsensus dioxin response elements located upstream of the IL6 start site. Such binding appears to render the promoter more permissive to IL1beta-induced binding of NF-kappaB components. The nature of the AHR-dependent increases in IL6 promoter transcriptional potential has been shown to involve a reorganization of repressive complexes as exemplified by the presence of HDAC1 and HDAC3. Dismissal of these HDACs correlates with post-translational modifications of promoter-bound NF-kappaB components in a time-dependent manner. Thus the AHR plays a role in derepressing the IL6 promoter, leading to synergistic IL6 expression in the presence of inflammatory signals. These observations may explain the association between enhanced expression of AHR and tumor aggressiveness. It is likely that AHR-mediated priming is not restricted to the IL6 promoter and may contribute to the expression of a variety of genes, which do not have consensus dioxin response elements.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20511231      PMCID: PMC2915674          DOI: 10.1074/jbc.M110.118570

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

1.  Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.

Authors:  A Badache; N E Hynes
Journal:  Cancer Res       Date:  2001-01-01       Impact factor: 12.701

2.  NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100.

Authors:  G Xiao; E W Harhaj; S C Sun
Journal:  Mol Cell       Date:  2001-02       Impact factor: 17.970

3.  Multiple transcription factors regulating the IL-6 gene are activated by cAMP in cultured Caco-2 cells.

Authors:  Dan D Hershko; Bruce W Robb; Guangju Luo; Per-Olof Hasselgren
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2002-11       Impact factor: 3.619

4.  Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB.

Authors:  Lin-feng Chen; Yajun Mu; Warner C Greene
Journal:  EMBO J       Date:  2002-12-02       Impact factor: 11.598

5.  IkappaB kinase alpha-mediated derepression of SMRT potentiates acetylation of RelA/p65 by p300.

Authors:  Jamie E Hoberg; Anita E Popko; Catherine S Ramsey; Marty W Mayo
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

Review 6.  Ah receptor agonists as endocrine disruptors: antiestrogenic activity and mechanisms.

Authors:  S Safe; F Wang; W Porter; R Duan; A McDougal
Journal:  Toxicol Lett       Date:  1998-12-28       Impact factor: 4.372

7.  The aryl hydrocarbon receptor attenuates tobacco smoke-induced cyclooxygenase-2 and prostaglandin production in lung fibroblasts through regulation of the NF-kappaB family member RelB.

Authors:  Carolyn J Baglole; Sanjay B Maggirwar; Thomas A Gasiewicz; Thomas H Thatcher; Richard P Phipps; Patricia J Sime
Journal:  J Biol Chem       Date:  2008-08-12       Impact factor: 5.157

8.  Activation of the aryl hydrocarbon receptor pathway enhances cancer cell invasion by upregulating the MMP expression and is associated with poor prognosis in upper urinary tract urothelial cancer.

Authors:  Masaru Ishida; Shuji Mikami; Eiji Kikuchi; Takeo Kosaka; Akira Miyajima; Ken Nakagawa; Makio Mukai; Yasunori Okada; Mototsugu Oya
Journal:  Carcinogenesis       Date:  2009-09-15       Impact factor: 4.944

Review 9.  Regulation of distinct biological activities of the NF-kappaB transcription factor complex by acetylation.

Authors:  Lin-Feng Chen; Warner C Greene
Journal:  J Mol Med (Berl)       Date:  2003-08-15       Impact factor: 4.599

10.  Ah receptor represses acute-phase response gene expression without binding to its cognate response element.

Authors:  Rushang D Patel; Iain A Murray; Colin A Flaveny; Ann Kusnadi; Gary H Perdew
Journal:  Lab Invest       Date:  2009-03-30       Impact factor: 5.662

View more
  52 in total

1.  Identification of a high-affinity ligand that exhibits complete aryl hydrocarbon receptor antagonism.

Authors:  Kayla J Smith; Iain A Murray; Rachel Tanos; John Tellew; Anthony E Boitano; William H Bisson; Siva K Kolluri; Michael P Cooke; Gary H Perdew
Journal:  J Pharmacol Exp Ther       Date:  2011-04-14       Impact factor: 4.030

Review 2.  Dioxins: diagnostic and prognostic challenges arising from complex mechanisms.

Authors:  Noel M Rysavy; Kristina Maaetoft-Udsen; Helen Turner
Journal:  J Appl Toxicol       Date:  2012-05-19       Impact factor: 3.446

Review 3.  Indole and Tryptophan Metabolism: Endogenous and Dietary Routes to Ah Receptor Activation.

Authors:  Troy D Hubbard; Iain A Murray; Gary H Perdew
Journal:  Drug Metab Dispos       Date:  2015-06-03       Impact factor: 3.922

Review 4.  Aryl hydrocarbon receptor ligands in cancer: friend and foe.

Authors:  Iain A Murray; Andrew D Patterson; Gary H Perdew
Journal:  Nat Rev Cancer       Date:  2014-12       Impact factor: 60.716

5.  The Ah receptor regulates growth factor expression in head and neck squamous cell carcinoma cell lines.

Authors:  Kaarthik John; Tejas S Lahoti; Kelly Wagner; Jarod M Hughes; Gary H Perdew
Journal:  Mol Carcinog       Date:  2013-04-27       Impact factor: 4.784

6.  Aryl hydrocarbon receptor ligand effects in RBL2H3 cells.

Authors:  Kristina Maaetoft-Udsen; Lori M N Shimoda; Hanne Frøkiær; Helen Turner
Journal:  J Immunotoxicol       Date:  2012-04-04       Impact factor: 3.000

7.  Liver tumor promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin is dependent on the aryl hydrocarbon receptor and TNF/IL-1 receptors.

Authors:  Gregory D Kennedy; Manabu Nukaya; Susan M Moran; Edward Glover; Samuel Weinberg; Silvia Balbo; Stephen S Hecht; Henry C Pitot; Norman R Drinkwater; Christopher A Bradfield
Journal:  Toxicol Sci       Date:  2014-04-09       Impact factor: 4.849

Review 8.  Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities.

Authors:  Curtis J Omiecinski; John P Vanden Heuvel; Gary H Perdew; Jeffrey M Peters
Journal:  Toxicol Sci       Date:  2010-11-08       Impact factor: 4.849

9.  Divergent Ah Receptor Ligand Selectivity during Hominin Evolution.

Authors:  Troy D Hubbard; Iain A Murray; William H Bisson; Alexis P Sullivan; Aswathy Sebastian; George H Perry; Nina G Jablonski; Gary H Perdew
Journal:  Mol Biol Evol       Date:  2016-08-02       Impact factor: 16.240

10.  Aryl Hydrocarbon Receptor Activation Synergistically Induces Lipopolysaccharide-Mediated Expression of Proinflammatory Chemokine (c-c motif) Ligand 20.

Authors:  Tejas S Lahoti; Jacob A Boyer; Ann Kusnadi; Gulsum E Muku; Iain A Murray; Gary H Perdew
Journal:  Toxicol Sci       Date:  2015-08-10       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.